Point Biopharma Revenue, Growth & Competitor Profile

DBA POINT BIOPHARMA USA INC

Company Profile & Annual Report for Point Biopharma

Access the complete profile.

Point Biopharma Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	4850 W 78th St Indianapolis, IN 46268

Note: Revenues for privately held companies are statistical evaluations.


Point Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Point Biopharma's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Point Biopharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Point Biopharma Annual Revenue and Growth Rate

Point Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Point Biopharma's revenues are gauged from an analysis of company filings.

Point Biopharma's Income Statement (based on Industry Averages)

Point Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Point Biopharma is developing and marketing. Point Biopharma doesn't have any recent trademark applications, indicating Point Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FROM NEUTRON TO PATIENT Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals	10/12/2021
CANSEEK Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical products used in the field of nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals	11/01/2020

See all trademarks and details in the Full Report.

Market Share of Point Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Point Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Point Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELI LILLY	Indianapolis, IN	100
ROCHE DIAGNOSTICS	Indianapolis, IN	5
EXELEAD	Indianapolis, IN	1
3C	Fishers, IN	1
POINT BIOPHARMA	Indianapolis, IN	0
SENTRY BIOPHARMA SERVICES	Indianapolis, IN	0

Future Competition: Point Biopharma's Fastest Growing Competitors

These companies are in the same general field as Point Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)